Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Ascorbic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.78 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.78 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.50 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.50 |
| ▸ | TST | Q16762 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 2/20 | 0.41 |
| ▸ | MANBA | O00462 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ascorbic Acid SCHEMBL165191 | 0.97 | MAPT (0.78) | MAPTLMNAL3MBTL1HSPD1HSPE1 | |
| Ascorbic Acid SCHEMBL7086565 | 0.94 | MAPT (0.73) | MAPTLMNAL3MBTL1HSPD1HSPE1 | |
| Ascorbic Acid SCHEMBL29857583 | 0.94 | MAPT (0.83) | MAPTLMNAL3MBTL1HSPD1HSPE1 | |
| Ascorbic Acid SCHEMBL15226289 | 0.92 | MAPT (0.86) | MAPTLMNAL3MBTL1HSPD1HSPE1 | |
| Ascorbic Acid SCHEMBL31356983 | 0.90 | MAPT (0.83) | MAPTLMNAL3MBTL1HSPD1HSPE1 | |
| Ascorbic Acid SCHEMBL28255170 | 0.90 | MAPT (0.83) | MAPTLMNAL3MBTL1HSPD1HSPE1 | |
| Ascorbic Acid SCHEMBL5968922 | 0.90 | MAPT (0.83) | MAPTLMNAL3MBTL1HSPD1HSPE1 | |
| Ascorbic Acid SCHEMBL10642367 | 0.90 | MAPT (0.83) | MAPTLMNAL3MBTL1HSPD1HSPE1 | |
| Ascorbic Acid SCHEMBL10535642 | 0.89 | MAPT (0.76) | MAPTLMNAL3MBTL1HSPD1HSPE1 | |
| Ascorbic Acid SCHEMBL21372605 | 0.89 | MAPT (0.81) | MAPTLMNAL3MBTL1HSPD1HSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105025712-B | Antimicrobial compositions | 西姆莱斯股份公司 | 2020-05-05 | — | — | CN | disclosed |
| EP-2414382-B1 | BLEACHING PEPTIDES FOR THE ACTIVATION OF THE PROTEASOME AND COMPOSITIONS COMPRISING THEM | ISP INVESTMENTS INC (US) | 2017-07-12 | — | — | EP | disclosed |
| EP-2421885-B1 | BLEACHING PEPTIDE HYDROLYSATE PROTEASOME ACTIVATOR AND COMPOSITIONS CONTAINING SAME | ISP INVESTMENTS INC (US) | 2015-02-25 | — | — | EP | disclosed |
| US-8722627-B2 | Proteasome-activating lightening peptidic hydrolyzates and compositions containing them | ISP INVESTMENTS INC. (US) | 2014-05-13 | — | — | US | disclosed |
| US-8530623-B2 | Proteasome-activating lightening peptides and compositions containing same | ISP INVESTMENTS INC. (US) | 2013-09-10 | — | — | US | disclosed |
| US-8309144-B2 | Use of a cruciferous protein hydrolysate as a depigmentation agent or for a cosmetic and/or pharmaceutical composition | ISP INVESTMENTS INC. (US) | 2012-11-13 | — | — | US | disclosed |
| US-20120100086-A1 | BLEACHING PEPTIDE HYDROLYZATE PROTEASOME ACTIVATOR AND COMPOSITIONS CONTAINING SAME | AVOCA LLC | 2012-04-26 | — | — | US | disclosed |
| EP-2421885-A1 | BLEACHING PEPTIDE HYDROLYSATE PROTEASOME ACTIVATOR AND COMPOSITIONS CONTAINING SAME | Isp Investments Inc. (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-2414382-A2 | NOVEL PROTEASOME-ACTIVATING LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME | ISP Investments Inc. (US) | 2012-02-08 | — | — | EP | disclosed |
| US-20120020904-A1 | NOVEL PROTEASOME-ACTIVATING LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME | PHARMACHEM LABORATORIES LLC | 2012-01-26 | — | — | US | disclosed |
| US-20110158926-A1 | Use of a cruciferous protein hydrolysate as a depigmentation agent or for a cosmetic and/or pharmaceutical composition | ISP INVESTMENTS INC. (US) | 2011-06-30 | — | — | US | disclosed |
| US-20100322886-A1 | USE OF A CRUCIFEROUS PROTEIN HYDROLYSATE AS A DEPIGMENTATION AGENT OR FOR A COSMETIC AND/OR PHARMACEUTICAL COMPOSITION | ISP INVESTMENTS INC. | 2010-12-23 | — | — | US | disclosed |
| WO-2010122245-A1 | BLEACHING PEPTIDE HYDROLYSATE PROTEASOME ACTIVATOR AND COMPOSITIONS CONTAINING SAME | ISP INVESTMENTS INC. (US) | 2010-10-28 | — | — | WO | disclosed |
| WO-2010112711-A2 | NOVEL PROTEASOME-ACTIVATING LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME | ISP INVESTMENTS INC. (US) | 2010-10-07 | — | — | WO | disclosed |
| WO-2010112713-A2 | NOVEL PROTEASOME-ACTIVATING LIGHTENING PEPTIDES AND COMPOSITIONS CONTAINING SAME | ISP INVESTMENTS INC. (US) | 2010-10-07 | — | — | WO | disclosed |
| EP-1776082-B1 | USE OF A CRUCIFEROUS PROTEIN HYDROLYSATE AS A DEPIGMENTATION AGENT OR FOR A COSMETIC AND/OR PHARMACEUTICAL COMPOSITION | SOC EXTRACTION PRINCIPES ACTIF (FR) | 2009-01-21 | — | — | EP | disclosed |
| US-20070274937-A1 | Use of a Cruciferous Protein Hydrolysate as a Depigmentation Agent or For a Cosmetic and/or Pharmaceutical Composition | DAL FARRA CLAUDE | 2007-11-29 | — | — | US | disclosed |
| EP-1776082-A1 | USE OF A CRUCIFEROUS PROTEIN HYDROLYSATE AS A DEPIGMENTATION AGENT OR FOR A COSMETIC AND/OR PHARMACEUTICAL COMPOSITION | SOCIETE D'EXTRACTION DES PRINCIPES ACTIFS SA (VINCIENCE) (FR) | 2007-04-25 | — | — | EP | disclosed |
| WO-2005107697-A1 | USE OF A CRUCIFEROUS PROTEIN HYDROLYSATE AS A DEPIGMENTATION AGENT OR FOR A COSMETIC AND/OR PHARMACEUTICAL COMPOSITION | SOCIETE D'EXTRACTION DES PRINCIPES ACTIFS SA VINCIENCE (FR) | 2005-11-17 | — | — | WO | disclosed |